alexa
Reach Us +44-1235425476
Radionuclide Therapy in Solid Tumors | List of High Impact Articles | PPts | Journals | Videos
ISSN: 2155-9619

Journal of Nuclear Medicine & Radiation Therapy
Open Access

Radionuclide Therapy in Solid Tumors

Search results for
Radionuclide Therapy in Solid Tumors

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

Clinical Oncology & Radiation Therapy

Singapore, Singapore
Share This Page

Radionuclide Therapy in Solid Tumors

Radionuclide Therapy in Solid Tumours is done by introducing radial dose of beta-particle-emitting and alpha-particle-emitting molecules localized either solely within endothelial cells of tumour vasculature or diffusing from the vasculature throughout the adjacent viable tumour cells.

Peptide receptor radionuclide therapy (PRRT) or hormone-delivered radiotherapy, which is otherwise known as Radionuclide therapy in solid tumors treatment has a major role. Radionuclide therapy in solid tumors recognition, a dose of radiation could prevent the tumor growth. Radionuclide therapy in solid tumors treatment radioactive substances are chemically combined with hormones. Radionuclide therapy in solid tumors, this substance known as NET is injected into patient.

Radionuclide Therapy in Solid Tumors

Expert PPTs

Speaker PPTs